Lawrence A. Kenyon

2019

In 2019, Lawrence A. Kenyon earned a total compensation of $1.9M as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 160% increase compared to previous year.

Compensation breakdown

Option Awards$1,419,880
Salary$425,000
Other$19,021
Total$1,863,901

Kenyon received $1.4M in option awards, accounting for 76% of the total pay in 2019.

Kenyon also received $425K in salary and $19K in other compensation.

Rankings

In 2019, Lawrence A. Kenyon's compensation ranked 6,290th out of 13,971 executives tracked by ExecPay. In other words, Kenyon earned more than 55.0% of executives.

ClassificationRankingPercentile
All
6,290
out of 13,971
55th
Division
Manufacturing
2,364
out of 5,692
59th
Major group
Chemicals And Allied Products
863
out of 2,189
61st
Industry group
Drugs
730
out of 1,875
61st
Industry
Biological Products, Except Diagnostic Substances
172
out of 389
56th
Source: SEC filing on February 22, 2021.

News

In-depth

You may also like